PT1121146E - Processo para influenciar celulas t hiperactivas por meio de enzimas proteoliticas - Google Patents

Processo para influenciar celulas t hiperactivas por meio de enzimas proteoliticas

Info

Publication number
PT1121146E
PT1121146E PT99953778T PT99953778T PT1121146E PT 1121146 E PT1121146 E PT 1121146E PT 99953778 T PT99953778 T PT 99953778T PT 99953778 T PT99953778 T PT 99953778T PT 1121146 E PT1121146 E PT 1121146E
Authority
PT
Portugal
Prior art keywords
hyperactive
cells
influencing
enzymes
proteolitic enzymes
Prior art date
Application number
PT99953778T
Other languages
English (en)
Inventor
Karl Ransberger
Gerhard Stauder
Original Assignee
Mucos Pharma Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mucos Pharma Gmbh & Co filed Critical Mucos Pharma Gmbh & Co
Publication of PT1121146E publication Critical patent/PT1121146E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21004—Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22002—Papain (3.4.22.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22033—Fruit bromelain (3.4.22.33), i.e. juice bromelain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT99953778T 1998-10-13 1999-10-12 Processo para influenciar celulas t hiperactivas por meio de enzimas proteoliticas PT1121146E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19847114A DE19847114A1 (de) 1998-10-13 1998-10-13 Beeinflussung von hyperaktiven T-Zellen durch proteolytische Enzyme

Publications (1)

Publication Number Publication Date
PT1121146E true PT1121146E (pt) 2004-10-29

Family

ID=7884290

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99953778T PT1121146E (pt) 1998-10-13 1999-10-12 Processo para influenciar celulas t hiperactivas por meio de enzimas proteoliticas

Country Status (7)

Country Link
EP (1) EP1121146B1 (pt)
AT (1) ATE270109T1 (pt)
DE (2) DE19847114A1 (pt)
DK (1) DK1121146T3 (pt)
ES (1) ES2223187T3 (pt)
PT (1) PT1121146E (pt)
WO (1) WO2000021547A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10018980A1 (de) * 2000-04-17 2001-11-08 Mucos Pharma Gmbh & Co Prophylaxe und Therapie von Diabetes mellitus I mit Hilfe proteolytischer Enzyme

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4130221C2 (de) * 1991-09-11 1997-08-07 Mucos Pharma Gmbh Verwendung von proteolytischen Enzymen zur Herstellung eines Medikaments zur Behandlung von Autoimmun-Krankheiten, an deren Entstehung Proteine mit einer C¶H¶2-Domäne beteiligt sind
DE4302060A1 (de) * 1993-01-26 1994-07-28 Mucos Pharma Gmbh & Co Verwendung von Bromelain zur Krebstherapie und/oder Metastasen-Prophylaxe
GB9412711D0 (en) * 1994-06-24 1994-08-17 Cortecs Ltd Medical use of bromelain
DE19726255C2 (de) * 1997-06-20 2000-03-16 Mucos Pharma Gmbh & Co Beeinflussung von Cytokinen durch proteolytische Enzyme und Rutosid
DE19726253C2 (de) * 1997-06-20 2000-03-16 Mucos Pharma Gmbh & Co Verwendung von mindestens einem proteolytischen Enzym und Rutosid zur Behandlung von Glomerulonephritis

Also Published As

Publication number Publication date
EP1121146A2 (de) 2001-08-08
WO2000021547A2 (de) 2000-04-20
ES2223187T3 (es) 2005-02-16
DK1121146T3 (da) 2004-10-25
DE19847114A1 (de) 2000-04-20
EP1121146B1 (de) 2004-06-30
DE59909869D1 (de) 2004-08-05
WO2000021547A3 (de) 2000-09-08
ATE270109T1 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
BR9814236A (pt) Enzima subtilase, sua variante, sequência de dna isolada, vetor de expressão, célula microbiana hospedeira, processo para produzir uma subtilase ou uma variante de subtilase, composição, e, uso de uma subtilase ou de uma variante de subtilase.
DE69940265D1 (de) Alzheimersche krankheit sekretase
DK1151297T3 (da) Fremgangsmåde til forøgelse af bindingsinteraktioner mellem medlemmer af specifikke bindingspar
DK0675951T3 (da) Enzym med endoglucanaseaktivitet
DK0938570T3 (da) Muteret alfa-amylase omfattende modifikation ved rester svarende til A210, H405 og/eller T412 i Bacillus licheniformis
BR0009362A (pt) Variante de uma alfa-amilase semelhante atermamyl precursora, construção de dna, vetorde expressão recombinante, célula, composição,processo para gerar uma variante de umaalfa-amilase semelhante a termamyl precursora,e, uso de uma variante de alfa-amilase
TW200745552A (en) HU-ASP 1 protease substrate and uses thereof
DK0832245T4 (da) Rekombinant hexoseoxidase, en fremgangsmåde til at fremstille samme samt anvendelse af et sådan enzym
HUP0301245A2 (hu) Eljárás K-vitamin-függż fehérjék elżállítására
ES2166010T3 (es) Produccion de acrilato de amonio.
AU2002354696A1 (en) Method for purifying an enzyme, a purified enzyme produced thereby, and use of this enzyme
DE60042209D1 (de) Enzymatische synthese von deoxyribonucleotiden
WO2003057138A3 (en) Expression of lysosomal hydrolase in cells expressing pro-n-acetylglucosamine-1-phosphodiester alpha-n-acetyl glucosimanidase
ATE226254T1 (de) Reagenz zur behandlung von arthritischen zustaenden
ATE131066T1 (de) Mittel zur hemmung von hiv-proteasen.
EP1118667A4 (en) NOVEL ENZYME COMPOSITIONS, PROCESS FOR PRODUCING SUCH COMPOSITIONS, AND USE THEREOF
FI921847A0 (fi) Farmaceutisk komposition som har endoproteolytisk aktivitet, foerfarande foer endoproteolytisk behandling av (prekursor)proteiner samt foerfarande foer (mikro)bio- logisk framstaellning av proteiner.
PT1121146E (pt) Processo para influenciar celulas t hiperactivas por meio de enzimas proteoliticas
WO2005007663A3 (en) Fluorogenic enzyme substrates and uses thereof
DE69828405D1 (de) Inhibitoren von cellulolytischen, xylanolytischen und beta-glukanolytischen enzymen
ES2079442T3 (es) Oxidacion enzimatica mejorada de cef c a acido glutaril-7-amino-cefalosporanico.
DE69515652D1 (de) Verwendung von dna oligomeren zur hemmung von hiv durch reduktion ribosomaler leserasterverschichtung
YU31697A (sh) Varijante aprotinina sa poboljšanim svojstvima
ATE282702T1 (de) Lytisches enzym
FR2815640B1 (fr) Procede de production de proteines par electropulsation de levures